Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Yangxin Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of heart failure and related cardiovascular conditions. It consists of multiple herbs including Panax notoginseng, Panax ginseng, Rhodiola crenulata, Aconitum carmichaeli, Ophiopogon japonicus, Astragalus membranaceus, Angelica sinensis, and Rehmannia glutinosa[1][4]. The decoction is believed to work by supporting "Yangqi" in the heart according to TCM theory and has demonstrated clinical benefits in improving symptoms and surrogate endpoints in patients with chronic heart failure[1][2][4]. Its mechanism involves multi-target modulation affecting hundreds of biological targets identified through network pharmacology approaches; however, precise molecular mechanisms remain under investigation[1]. Clinical trials are ongoing to evaluate its efficacy and safety for heart failure with preserved ejection fraction (HFpEF)[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Yangxin Decoction.